Eurofins Discovery Launches DiscoveryAI SAFIRE: A New AI Platform for Drug Discovery
The drug discovery process is unduly time-consuming and expensive. Extensive laboratory testing is required to evaluate potential drug candidates for absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Compounds that fail to meet acceptable thresholds for these properties may be unsafe or ineffective in humans, leading to high failure rates in clinical trials. But what if…


